Market Wrap
Markets moved on two fronts: a vaccine trial success lifted biotech sentiment, while a major chipmaker's financing maneuver signaled confidence in deal-making despite elevated rates. Tech and healthcare diverged on fundamentals rather than macro.
- Moderna stock doubles on cancer vaccine Phase 3 trial results
- Broadcom raises billions in debt to fund chip acquisition
- Samsung announces shareholder returns including third-quarter dividend
Sources: MarketWatch, Decrypt, CNBC, Cointelegraph, The Block, The Defiant, CoinDesk
This article is for information only and is not financial advice.
What the market did
Each figure is this site’s own reading, with what it was measured against. A blank is a reading nobody took, not a zero. The before-the-headline window prints the rate a RANDOM hour clears the same bar, because a hit rate without its null is not a finding.
Cite this
Archived copy · an independent capture of this page at the Internet Archive, kept so this report can be checked against what it said on the day
← more bytes